title: Measuring response to therapy using FDG PET: semi-quantitative and full kinetic analysis.
abstract: OBJECTIVE
  Imaging with positron emission tomography (PET) using (18)F-2-fluoro-2-deoxy-D: -glucose (FDG) plays an increasingly important role for response assessment in oncology. Several methods for quantifying FDG PET results exist. The goal of this study was to analyse and compare various semi-quantitative measures for response assessment with full kinetic analysis, specifically in assessment of novel therapies.
  
  
  METHODS
  Baseline and response dynamic FDG studies from two different longitudinal studies (study A: seven subjects with lung cancer and study B: six subjects with gastrointestinal cancer) with targeted therapies were reviewed. Quantification of tumour uptake included full kinetic methods, i.e. nonlinear regression (NLR) and Patlak analyses, and simplified measures such as the simplified kinetic method (SKM) and standardized uptake value (SUV). An image-derived input function was used for NLR and Patlak analysis.
  
  
  RESULTS
  There were 18 and 9 lesions defined for two response monitoring studies (A and B). In all cases there was excellent correlation between Patlak- and NLR-derived response (R (2) > 0.96). Percentage changes seen with SUV were significantly different from those seen with Patlak for both studies (p < 0.05). After correcting SUV for plasma glucose, SUV and Patlak responses became similar for study A, but large differences remained for study B. Further analysis revealed that differences in responses amongst methods in study B were primarily due to changes in the arterial input functions.
  
  
  CONCLUSIONS
  Use of simplified methods for assessment of drug efficacy or treatment response may provide different results than those seen with full kinetic analysis.
authors.affiliation: Department of Nuclear Medicine and PET Research, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands.
authors.forename: Patsuree
authors.initials: P
authors.lastname: Cheebsumon
authors.forename: Linda M
authors.initials: LM
authors.lastname: Velasquez
authors.forename: Corneline J
authors.initials: CJ
authors.lastname: Hoekstra
authors.forename: Wendy
authors.initials: W
authors.lastname: Hayes
authors.forename: Reina W
authors.initials: RW
authors.lastname: Kloet
authors.forename: Nikie J
authors.initials: NJ
authors.lastname: Hoetjes
authors.forename: Egbert F
authors.initials: EF
authors.lastname: Smit
authors.forename: Otto S
authors.initials: OS
authors.lastname: Hoekstra
authors.forename: Adriaan A
authors.initials: AA
authors.lastname: Lammertsma
authors.forename: Ronald
authors.initials: R
authors.lastname: Boellaard
mesh_terms: D019540:Area Under Curve; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D007700:Kinetics; D008297:Male; D009369:Neoplasms / Q000000981:diagnostic imaging / Q000628:therapy; D017711:Nonlinear Dynamics; D049268:Positron-Emission Tomography; D012044:Regression Analysis; D015203:Reproducibility of Results; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D019788:Fluorodeoxyglucose F18